Sellas Life Sciences CEO and founder Angelos Stergiou joins 'Fox & Friends' to discuss trial results for a new acute myeloid leukemia vaccine.
November 17, 2026

Leukemia vaccine trial shows 41% lower risk of death

Sellas Life Sciences CEO and founder Angelos Stergiou joins 'Fox & Friends' to discuss trial results for a new acute myeloid leukemia vaccine.

Latest Videos

Breakfast with 'Friends'

Talking Points

Cooking with 'Friends'

America Cooks Together

FOX & Friends Library

FOX News may be compensated or earn a commission if you buy through our referral links.